Multicenter study on the efficacy and safety of lomefloxacin versus trimethoprim and sulfamethoxazole in the treatment of lower urinary tract infection in women;Estudo multicentrico da eficacia e seguranca da lomefloxacina versus sulfametoxazol/trimetoprim no tratamento de cistite em mulheres

Revista Brasileira de Medicina

Volumn 53, Issue 4, 1996, Pages 290-294

  Aldrighi, José ^a   Silva, Adelino Amaral ^b   Neto, Jorge Abi Saab ^c   Pagani, José Pedro ^d   Neto, José Remijio ^e   Coimbra, Murilo Gonçalves ^f  

^a Faculdade Cie Medicas da S Casa S   (Brazil)

^b Hospital Regional Asa Norte   (Brazil)

^c FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^d Faculdade Evangelica Med do Parana   (Brazil)

^e FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^f FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; LOMEFLOXACIN;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG TOLERANCE; ESCHERICHIA COLI; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; KLEBSIELLA; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NAUSEA; NERVOUSNESS; ORAL DRUG ADMINISTRATION; PROTEUS MIRABILIS; RANDOMIZED CONTROLLED TRIAL; STOMACH PAIN; URINARY TRACT INFECTION;

EID: 0030391848     PISSN: 00347264     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Andrade-Villanueva, J.; Flores-Gaxiola, A.; Lopez-Guillen, P.; Aguirre-Avalos, G.; Morfin-Otero, R.; Rodriguez-Noriega, E. Comparison of the safety and efficacy of lomefloxacin and trimethoprim/sulfamethoxazole in the treatment of uncomplicated urinary tract infections: results from a multicenter study. Am J Med, 92 (Suppl 4A): 4A-71S, 1992.
2. Bicalho, O.J. Eficácia e segurança da lomefloxacina no tratamento de infecções não complicadas do trato urinário. RBM 50: 686-690, 1993.
3. Carvalho, WA Quinolonas: estruturaquímica, farmacocinética e mecanismo de ação. RBM 51: 557-579, 1994.
4. Chin, N.X.; Novelli, A.; Neu, H.C. In vitro activity of lomefloxacin (SC-47111, NY-198), a new difluoroquinolone 3-carboxylic acid, compared with those of other quinolones. Antimicrob Agents Chemother 32: 656-662, 1988.
5. Cox, C.E. A comparison of the safety and efficacy of lomefloxacin and ciprofloxacin in the treatment of complicated or recurrent urinary tract infections. Am. J. Med. 92 (Suppl 4A): 4A-82S, 1992.
6. Girão, M.J.B.C.; Sartori, M.G.P.F.; Baracat, E.G.; Lima, G.R. Infecção urinäria na mulher. RBM - Ginecologia & Obstetricia 5: 65-77, 1994.
7. Gros, I.; Carbon, C. Pharmacokineticsof lomefloxacin in healthy volunteers: comparison of 400 mg once daily and 200 mg twice daily given orally for 5 days. Antimicrob Agents Chemother 34: 150-152, 1990.
8. Hease, D.A; Harding, G.K.M.; Thomson, M.J.; Kennedy, J.K.; Urias, B.A; Ronald, A.R. Compa-rative trial of norfloxacin and trimethoprim-sulfa-methoxazole in the treatment of women with localized acute, symptomatic urinary tract infections and antimicrobial effect on periurethral and fecal microflora. Antimicrob Agents Chemother 26:481-484, 1994.
9. Hirose,T.; Okezaki, E.; Kato, H.; Ito, Y.; Inoue, M.; Mitsuhashi, S. In vitro and in vivo activity of NY-198, a new difluorinated quinolone. Antimicrob Agents Chemother 31: 854-859, 1987.
10. Leroy, A.; Filastre, J.P.; Humbert, G. Lomefloxacin pharmacokinetics in subjects with normal and impaired renal function. Antimicrob Agents Chemother 34: 17-20, 1990.
11. Lesher, G.Y.; Froelich, E.J.; Gruett, M.D.; Bailey, J.H.; Brundage, R.P. 1,8-Naphthyridine derivatives: a new class of chemotnerapeutic agents. J. Med. Pharm. Chem. 5: 1063-1065, 1962.
12. Malinverni, R.; Glauser, M.P. Comparative studies of fluoroquinolones in the treatment of urinary tract infections. Rev. Infect. Dis. 10 (Supp 1): S153-S163, 1988.
13. Mant, T.G.K. Multiple-dose pharmacokinetics of lomefloxacin: rationale for once-a-day closing. Am. J. Med. 92 (Suppl 4A): 4A-26S, 1992.
14. Morrison, P.J.; Mant, T.G.K.; Norman, G.X; Robinson, J. Kunka, R. L Pharmacokinetics and tolerance of lomefloxacin after sequentially increasing oral doses. Antimicrob Agents Chemother 32: 1503-1507, 1988.
15. Naber, K.G. Use of quinolones in urinary tract infections and prostatitis. Rev. Infect. Dis. 11 (Suppl 5): S1321-S1337, 1989.
16. Ralma, P.C.R. Infecções do trato urinário: terapêutica. In: Forum Maxaquin: Novo perfil farmacocinético dentre as quinolonas. Rio Atlântica Suite Hotel. Rio de Janeiro, 26 de Junho de 1992, pp. 12-14.
17. Perez-Ruvalcaba, J.A.; Quintero-Perez, N.P.; Morales-Reyes, J.J.; Huintron-Ramirez, J.A.; Rodriguez-Chagollan, J.J.; Rodriguez-Noriega, E. A double blind comparison of ciprofloxacin and trimethoprim-sulfamethoxazole in the treatment of patients with urinary tract infections. Rev. Infect. Dis. 10 (Suppl 1): S164-165, 1988.
18. Piddock, L.J.V.; Hall, M.C.; Wise, R. Mechanism of action of lomefloxacin Antimicrob Agents Chemother 34: 1088-1093, 1990.
19. Rustige, C.; Wiedeman, B. Antibacterial activity of lomefloxacin in a pharmacokinetic in vitro model. Antimicrob Agents Chemother 34: 1107-1111, 1990.
20. Segreti, J.; Nelson, J.A.; Goodman, L.J.; Kaplan, R.L.; Trenolme, G.M. In vitro activity of lomefloxacin and temafloxacin against pathogens causing diarrhea. Antimicrob Agents Chemother 33: 1385-1387, 1989.
21. Stone, J.W.; Andrews, J.M.; Ashby, J.P.; Griggs, D.; Wise, R. Pharmacokinetics and tissue penetration of orally administered lomefloxacin. Antimicrob Agents Chemother 32: 1508-1510, 1988.
22. Talbot, H.; Romanowski, B. In vitro activity of lomefloxacin, tetracycline, penicilin, spectinomycin, and ceftriaxone against Neisseria gonorrhoeae and Chlamydia trachomatis. Antimicrob Agents Chemother 33: 2049-2051, 1989.
23. Tomioka, E.; Podgaec, S.; Barros, M.S.; Fucs, M. Lomefloxacina em esquema de dose única de 400 mg/dia por três dias no tratamento das cistites em ginecologia. RBM-Ginecologia & Obstetricia 4: Agosto, 1993.
24. Wadworth, A.N. & Goa, K. L Lomefloxacin: a review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs 42: 1018-1060, 1991.
25. Wise, R.; Andrews, J.M.; Ashby, J.P.; Matthews, R.S. In vitro activity of lomefloxacin, a new quinolone antimicrobial agent, in comparison with those of other agents. Antimicrob Agents Chemother 32: 617-622, 1988.
26. Wolfson, O.S.; Hooper, D.C. Treatment of genitourinary tract infections with fluoroquinolones activity in vitro, pharmacokinetics, and clinical efficacy in urinary tract infections and prostatitis. Antimicrob Agents Chemother 33: 1655-1661, 1989.
27. Koff, Walter. Estudo comparativo entre lomefloxacina e ofloxacina no tratamento da prostatite bacteriana crônica RBM 53. 88-91, 1996.